share_log

Watching ESSA Pharma; Piper Sandler Reiterates Overweight, $20 Price Target

Watching ESSA Pharma; Piper Sandler Reiterates Overweight, $20 Price Target

觀看 ESSA Pharma;派珀·桑德勒重申增持,目標股價爲20美元
Benzinga Real-time News ·  2022/10/26 10:24

Watching ESSA Pharma; Piper Sandler Reiterates Overweight, $20 Price Target

觀看 ESSA Pharma;派珀·桑德勒重申增持,目標股價爲20美元

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論